Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

EPT Disclosure

12 May 2009 09:28

RNS Number : 0875S
Credit Suisse Securities (Eur) Ltd
12 May 2009
 

FORM 38.5 (b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION 

Name of exempt principal trader

Credit Suisse Securities (Europe) Limited

Company dealt in

Raven Russia Limited

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary Shares

Date of dealing

11-May-2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

19290

0.004

 

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell 

 

 

 

 

Total

19290

0.004

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) 

Class Of Relevant Security : 

Long

Short

(1) Relevant Securities 

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase\sell 

 

 

Total

 

 

(c) Rights to subscribe (Note 2) 

Class of relevant security:

Details

 

 

3. DEALINGS (Note 3)

(a) Purchases and sales 

Purchase/sale

Number of securities

Price per unit (Note 4)

Buy

10000

0.275 (GBP)

Buy

4169

0.275 (GBP)

Buy

1163

0.275 (GBP)

Buy

1100

0.275 (GBP)

Buy

1090

0.275 (GBP)

Buy

583

0.2725 (GBP)

Buy

469

0.275 (GBP)

Buy

322

0.275 (GBP)

Buy

200

0.275 (GBP)

Buy

194

0.275 (GBP)

(b) Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

 

 

 

 

(c) Options transactions in respect of existing securities 

(i) Writing, selling, purchasing or varying 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 6)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

(ii) Exercising 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

(d) Other dealings (including new securities) (Note 3) 

Nature of transaction (Note 7)

Details

Price per unit (if applicable) (Note 4)

 

 

 

4. OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8)  No

Date of disclosure

12-May-2009 07:56:11

Contact name

Collins,Carolyn/ Crawley, Simon

Telephone number

44 20 7888 0241

Name of offeree/offeror with which connected

Raven Russia Limited

Nature of connection (Note 9)

BROKER

Notes  The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMSFWSAESUSEEI
Date   Source Headline
3rd Mar 20117:00 amRNSScrip Dividend Circular
1st Mar 20117:00 amRNSTotal Voting Rights
28th Feb 20117:00 amRNSAcquisition
17th Feb 20114:21 pmRNSPreference Share Dividend - Replacement
17th Feb 20117:00 amRNSPreference Share Dividend
14th Feb 20117:01 amRNSChange of Joint Broker
14th Feb 20117:00 amRNSChange of Nominated Adviser
2nd Feb 20117:00 amRNSBlock Listing Six Monthly Return
1st Feb 20117:00 amRNSTotal Voting Rights
11th Jan 20115:40 pmRNSDirector/PDMR Shareholding
7th Jan 20117:00 amRNSIssue of Preference Shares
4th Jan 20117:00 amRNSTotal Voting Rights
31st Dec 20107:00 amRNSDirector/PDMR Shareholding
30th Dec 20107:00 amRNSIssue of Preference Shares
15th Dec 20109:37 amRNSDirector/PDMR Shareholding
10th Dec 20103:35 pmRNSDirector/PDMR Shareholding
2nd Dec 20107:00 amRNSScrip Dividend Circular
1st Dec 20107:00 amRNSVoting Rights and Capital
24th Nov 20105:36 pmRNSDirector/PDMR Shareholding
19th Nov 20107:00 amRNSInterim Management Statement
18th Nov 20107:00 amRNSPreference Share Dividend
11th Nov 20103:24 pmRNSDirector/PDMR Shareholding
10th Nov 20109:37 amRNSHolding(s) in Company
1st Nov 20107:00 amRNSVoting Rights and Capital
27th Oct 20101:53 pmRNSHolding(s) in Company
26th Oct 20107:00 amRNSDirector/PDMR Shareholding
26th Oct 20107:00 amRNSDirector/PDMR Shareholding
26th Oct 20107:00 amRNSVoting Rights and Capital
26th Oct 20107:00 amRNSVoting Rights and Capital
20th Oct 20105:32 pmRNSDirector/PDMR Shareholding
20th Oct 20105:32 pmRNSDirector/PDMR Shareholding
14th Oct 20109:07 amRNSDirector/PDMR Shareholding
13th Oct 20109:21 amRNSHolding(s) in Company
30th Sep 20109:25 amRNSDirector/PDMR Shareholding
30th Sep 20107:00 amRNSVoting Rights and Capital
29th Sep 20104:00 pmRNSUpdate re Tender Offer and Notice of EGM
29th Sep 20107:00 amRNSIssue of Preference Shares
28th Sep 20106:04 pmRNSResult of Written Resolution
17th Sep 20104:34 pmRNSDirector/PDMR Shareholding
15th Sep 20104:37 pmRNSDirector/PDMR Shareholding
6th Sep 20109:08 amRNSAmendments to Warrant Instrument
2nd Sep 20107:00 amRNSScrip Dividend Circular
1st Sep 20104:18 pmRNSHolding(s) in Company
31st Aug 20107:00 amRNSHalf Yearly Report
31st Aug 20107:00 amRNSVoting Rights and Capital
26th Aug 20103:26 pmRNSNotice of Results
19th Aug 20102:54 pmRNSPreference Share Dividend
16th Aug 20103:37 pmRNSHolding(s) in Company
12th Aug 20101:50 pmRNSHolding(s) in Company
5th Aug 20105:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.